跳至主要内容
临床试验/NCT00820638
NCT00820638Unknown1 期

Myomo NeuroRobotic System Home Safety Study For Use by Stroke Survivors for Upper Extremity Rehabilitation in Their Homes

Myomo2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
1 期
发起方
Myomo
入组人数
25
试验地点
2
主要终点
No reported adverse events

研究概览

简要总结

Up to 25 subjects will use the Myomoe100 in the home setting under the distant supervision of an occupational therapist. We will look to see if they can perform functional activities safely without adverse events.

详细描述

Hypothesis Subjects can safely use the Myomo e100 NeuroRobotic System in the home.

Primary Outcome Measures:

  1. Safety:

  2. Safety of the device will be measured by the number of unanticipated or significant device related adverse events reported over a three week period of time. Minor known risks anticipated from device use are mild muscle soreness and fatigue. These will not be considered adverse events.

Secondary objectives & outcome measures:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • A current medical history of uncontrolled cardiovascular, or pulmonary disease, or other disease that would preclude involvement in a therapeutic treatment - Subjects must be able to tolerate a 45 minute upper-extremity therapy session in order to participate.
  • History of neurological disorder other than stroke- other neurological disorders may affect the upper extremity motor performance of subjects.
  • Other significant pain or skin irritation in the upper extremity that would be exacerbated if by the use of the brace - While wearing the brace, the system is pressed close to the upper arm and strapped around it. If the subject suffers from dermal breakdown or other skin conditions that may be aggravated by such a situation, they should not be involved in the study.
  • Substantial contracture of elbow - The system cannot work in the presence of reduced range of motion due to contractures. A substantial contracture is defined as greater than 20 degrees of elbow flexion contracture measured at the baseline evaluation.
  • Severe sensory loss: Score of 2 on the NIH stroke scale for sensory impairment. The system can work on subjects with sensory loss, however the concern is that a subject with severe sensory loss would not know if the system was applying too much force to the arm or if a strap was too tight and therefore not be able to inform their clinician.
  • Use of Botox injections in shoulder, arm or hand for the 3 months prior to study start and throughout the duration of the research study. - the use of Botox may alter the subject's performance on upper extremity motor tasks that are being assessed in the research
  • Cognitive or perceptual deficits sufficiently severe enough to interfere with ability to follow instructions- If the subject is unable to understand and follow simple instructions or express if the presence of pain, they should not be included. If the subject scores <69 on the Modified Mini Mental Exam or, if in the opinion of the principle investigator the subject can not safely participate in the study, the subject will be excluded.

结局指标

主要结局

No reported adverse events

时间窗: 3 weeks of home use

次要结局

未报告次要终点

研究者

发起方
Myomo
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

Myomo e100 NeuroRobotic System Home Safety Study | 临床试验